Adagio Medical (ADGM) Stock Price, News & Analysis

Company Overview

Adagio Medical, Inc. (NASDAQ: ADGM) is a medical device company focused on the development and commercialization of a noninvasive system for monitoring intracranial pressure (ICP). The company’s proprietary technology uses tympanic membrane displacement to provide clinicians with real-time estimates of ICP without the risks associated with invasive catheter methods. This approach is designed to improve patient safety, reduce complications, and streamline neurological monitoring in acute and critical care settings.

At the core of Adagio Medical’s pipeline is its ADGM System, which is intended for use in hospitals, emergency departments, and other clinical environments where rapid and accurate assessment of ICP is crucial. The system leverages advanced signal processing and hardware integration to capture subtle changes in ear canal pressure, translating these measurements into clinically actionable ICP values. Adagio Medical is pursuing regulatory review in key markets and has engaged in pilot studies with leading medical institutions to validate performance and ease of use.

Headquartered in Milpitas, California, Adagio Medical serves a global audience of neurosurgeons, neurologists, and critical care specialists. The company has established collaborations with academic medical centers and research organizations to further refine its technology and expand potential applications, including traumatic brain injury, hydrocephalus management, stroke care, and pediatric neurology. These partnerships help support ongoing clinical trials and product development initiatives aimed at broadening the system’s utility across various patient populations.

Led by CEO Keld Refsgaard, PhD, Adagio Medical draws upon a team of engineers, clinicians, and regulatory experts to drive innovation and navigate complex approval pathways. The company’s management emphasizes a commitment to scientific rigor, patient-centric design, and strategic collaboration as it works toward commercial launch and market adoption of its noninvasive ICP monitoring solution.

Key Stats

• Today's Range: $0.74 to $0.77
• 50-Day Range: $0.72 to $1.63
• 52-Week Range: $0.70 to $2.58
• Volume: 28,053 shs
• Average Volume: 111,307 shs
• Market Capitalization: $16.77 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.50
• Consensus Rating: Hold

Adagio Medical Stock Analysis - MarketRank™

Adagio Medical scored higher than 64% of companies evaluated by MarketBeat, and ranked 335th out of 868 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Hold

Consensus Rating

Adagio Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Adagio Medical has a consensus price target of $3.50, representing about 363.0% upside from its current price of $0.76.

Amount of Analyst Coverage

Adagio Medical has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Adagio Medical are expected to decrease in the coming year, from ($1.58) to ($2.33) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Adagio Medical is -0.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Adagio Medical is -0.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Adagio Medical has a P/B Ratio of 1.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.19% of the float of Adagio Medical has been sold short.

Short Interest Ratio / Days to Cover

Adagio Medical has a short interest ratio ("days to cover") of 0.77, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Adagio Medical has recently decreased by 34.69%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Adagio Medical does not currently pay a dividend.

Dividend Growth

Adagio Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

Adagio Medical has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Adagio Medical this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for ADGM on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Adagio Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

5.20% of the stock of Adagio Medical is held by insiders.

Percentage Held by Institutions

48.08% of the stock of Adagio Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/12/2026
• Today: 6/01/2026
• Next Earnings (Estimated): 8/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Trading
• Current Symbol: NASDAQ:ADGM
• Previous Symbol: NASDAQ:ADGM
• CIK: 2006986
• Web: adagiomedical.com
• Phone: (212) 284-2300
• Fax: N/A
• Employees: 87
• Year Founded: 2023

Price Target and Rating

• Average Price Target for Adagio Medical: $3.50
• High Price Target: $4.00
• Low Price Target: $3.00
• Potential Upside/Downside: +363.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.53)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$25.08 million
• Net Margins: N/A
• Pretax Margin: -57,254.02%
• Return on Equity: -382.50%
• Return on Assets: -64.98%

Debt

• Debt-to-Equity Ratio: 4.00
• Current Ratio: 1.85
• Quick Ratio: 1.66

Sales & Book Value

• Annual Sales: $600 thousand
• Price / Sales: 27.95
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.59 per share
• Price / Book: 1.28

Miscellaneous

• Outstanding Shares: 22,210,000
• Free Float: 21,055,000
• Market Cap: $16.77 million
• Optionable: N/A
• Beta: -0.19